• SENSEX 76,295.10
    -322.34 (--0.42%)
  • BANKNIFTY 51,348.05
    520.55 (+1.02%)
  • Mazagon Dock
    2,720.00 2,929.98(%)
  • Tejas Networks
    902.70 1,495.10(%)
  • Reliance Industr
    1,234.55 1,156.00(%)
  • Kalyan Jewellers
    497.15 337.00(%)
  • Adani Power
    538.00 896.75(%)
  • Hind.Aeronautics
    4,309.00 5,675.00(%)
  • TCS
    3,396.10 3,457.35(%)
  • Bharat Electron
    288.30 340.35(%)
  • Persistent Sys
    4,783.75 3,232.60(%)
  • Vodafone Idea
    8.06 6.60(%)
  • Tata Motors
    655.20 606.20(%)
  • Infosys
    1,485.10 1,359.10(%)
  • Emcure Pharma
    1,040.30 911.75(%)
  • Jio Financial
    231.75 394.70(%)
  • Reliance Power
    44.44 54.25(%)
  • IndusInd Bank
    714.65 1,576.00(%)
  • ICICI Bank
    1,306.55 1,048.35(%)
  • Zomato Ltd
    214.00 304.50(%)
  • Zydus Lifesci.
    949.85 1,323.90(%)
  • ICICI Pru. BSE
    999.99 998.75(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Strides Pharma Science Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 16996.0
  • ISIN : INE939A01011
669.55 3 (0.42%)
  • As on 03 Apr 2025 (EOD)

  • Today’s Low

    652.80

  • Today’s High

    675.65

  • Open

    667.00

  • Perv Close

    666.75

  • 52W Low

    301.13

  • 52W High

    760.95

Key Indicators

  • P/E(TTM)

    69.83

  • Mar.Cap (₹Cr.)

    6,170.75

  • Div & Yield %

    0.37

  • Book Value(₹)

    381.63

  • Debt-Equity Ratio

    0.42

  • AGM Date

    02-Apr-2025

  • EPS

    9.59

  • P/E Ratio

    69.83

Financials Ratios

  • Debt-Equity Ratio

    1.28

  • Mar.Cap (₹Cr.)

    6,170.75

  • RONW (%)

    0.00

  • ROCE (%)

    0.00

Score Board

  • Equity (₹ in Cr.)

    92.16

  • BV (₹)

    381.60

  • Sales( ₹ in Cr.)

    2,153.26

  • NP (in Cr.)

    70.86

  • NP Var(%)

    237.0

  • Div%

    25.0

  • CPS (₹)

    16.90

  • EPS (₹)

    7.70

  • Traded Value (₹ in Lakhs)

    6,171.68

  • 52 Week High

    760.95

  • 52 Week Low

    301.13

  • Price BSE

    670.0

  • Price NSE

    670.00

  • Market Capital( in Cr.)

    6,171.68

  • P/C Ratio

    39.70

  • P/E Ratio

    87.10

  • Price Vs.BV

    7.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 2,153.26 1,854.50 1,979.00 1,857.57 1,691.93 1,537.44
Excise Duty 2,048.17 1,745.16 1,908.03 1,776.54 1,541.10 1,356.43
Net Sales 2,153.26 1,854.50 1,979.00 1,857.57 1,691.93 1,537.44
Other Income 72.31 84.07 123.49 117.09 93.07 114.61
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 2,225.56 1,938.56 2,102.49 1,974.65 1,785.00 1,652.04
EXPENDITURE :
Raw Materials 2,048.17 1,745.16 1,908.03 1,776.54 1,541.10 1,356.43
Power & Fuel Cost 2,048.17 1,745.16 1,908.03 1,776.54 1,541.10 1,356.43
Employee Cost 335.21 267.01 272.09 272.72 230.23 223.21
Other Manufacturing Expenses 89.97 65.19 72.31 84.56 85.37 47.68
Selling & Administrative Expenses 168.38 182.64 260.83 171.51 117.95 132.91
Miscellaneous Expenses 89.97 65.19 72.31 84.56 85.37 47.68
Less : Pre-operative Expenses Capitalised :
Total Expenditure 2,150.58 1,988.32 2,080.98 1,863.02 1,648.56 1,535.49
Operating Profit 197.95 175.57 195.63 180.68 161.96 115.77
Interest 167.93 138.68 74.24 65.34 66.84 54.09
Gross Profit 69.62 -64.76 21.51 111.64 136.45 113.03
Depreciation 84.67 93.62 104.37 99.34 94.24 83.00
Profit Before Tax 69.62 -64.76 21.51 111.64 136.45 113.03
Tax 0.31 -49.84 2.09 21.02 15.20 22.39
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 3.82 -19.60 10.98 -0.26 -2.59 -1.96
Reported Net Profit 65.49 4.68 180.19 78.24 120.28 114.41
Extraordinary Items 69.62 -64.76 21.51 111.64 136.45 113.03
Adjusted Net Profit 65.49 4.68 180.19 78.24 120.28 114.41
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 -4.70
Statutory Appropriations 22.97 13.55 0.00 22.42 125.39 26.86
P & L Balance carried down 65.49 4.68 180.19 78.24 120.28 114.41
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 25.00 15.00 0.00 25.00 140.00 30.00
Dividend Per Share(Rs) 2.50 1.50 0.00 2.50 14.00 3.00
Earnings Per Share-Unit Curr 7.20 0.52 20.08 8.73 13.43 12.33
Book Value 22.97 13.55 0.00 22.42 125.39 26.86
Book Value(Adj)-Unit Curr 22.97 13.55 0.00 22.42 125.39 26.86

Shareholding Pattern

  • Promoter Group

    26.82%

  • Public Share Holding

    73.18%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 20,711,925 22.47 20,711,925 5
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 4,008,782 4.35 4,008,782 10
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 24,720,707 26.82 24,720,707 15
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 8,125 0.01 8,125 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 9,025 0.01 7,999 7
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 26,250,580 28.48 26,250,580 236
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 3,965,091 4.30 3,965,091 6
Mutual Funds / UTI 10,011,160 10.86 10,011,160 12
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,608,677 1.75 1,608,677 21
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 41,852,658 45.41 41,851,632 283
2] Non Institution
Bodies Corporate 2,599,564 2.82 2,598,446 1,008
Clearing Members 0 0.00 0 0
Directors of their Relatives 25,000 0.03 25,000 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,964,688 2.13 1,963,072 1,418
Foreign Non Institution Other 21,000 0.02 21,000 1
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 6,779,211 7.36 6,779,211 88
Individuals holding nominal share capital up to Rs. 1 lakh 12,450,047 13.51 12,384,852 107,959
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 1,749,839 1.90 1,749,683 3,464
Sub Total 25,589,349 27.77 25,521,264 113,939
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 92,162,714 100.00 92,093,603 114,237

Company Background

Strides Pharma Science LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Strides Pharma Science Ltd
  • BSE Code : 16996.0
  • ISIN : INE939A01011

  • Incorporation Year

    1990

  • Registered Office

    No 201 Devavrata Sector 17
    Vashi, Navi Mumbai,
    Maharashtra-400703

  • Telephone

    91-22-27892924/27893199

  • FAX

    91-22-27892942

  • Chairman

    Arun Kumar

  • Managing Director

    Badree Komandur

  • Company Secretary

    Manjula Ramamurthy

  • Auditor

    B S R & Co LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Strides Pharma Science Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Strides Pharma 669.65 2,225.56 2,153.26 69.90 4.68
Abbott India 29,572.60 6,097.18 5,848.91 47.09 44.71
Astrazeneca Phar 8,100.10 1,330.33 1,295.53 208.82 33.26
P & G Health Ltd 5,259.35 1,166.89 1,151.26 36.90 39.76
Glaxosmi. Pharma 2,776.60 3,530.73 3,407.25 55.21 44.44
Cipla 1,452.70 17,645.00 16,574.34 24.90 20.10
Amrutanjan Healt 645.10 437.58 421.23 37.81 20.84
Fermenta Biotec. 292.05 315.24 307.09 27.68 4.10
Guj. Themis Bio. 272.20 174.19 169.82 56.36 44.82
Bliss GVS Pharma 120.00 638.96 605.46 27.46 11.19
Ambalal Sarabhai 37.31 11.70 3.81 15.94 1.92